Literature DB >> 15558684

Metabolic studies on the total phenolic acids from the roots of Salvia miltiorrhiza in rats.

Jinlan Zhang1, Yun He, Ming Cui, Lie Li, Hailan Yu, Guifeng Zhang, Dean Guo.   

Abstract

Phenolic acids are the main active constituents of Salvia miltiorrhiza Bunge. The metabolism of total phenolic acids from the roots of Salvia miltiorrhiza in rats was investigated. A sample preparation method combining the solid-phase extraction with liquid-liquid extraction was established to separate metabolites from the biological matrix. HPLC-UV and HPLC-MS methods were employed to analyze the metabolites. Five metabolites (M1-M5) were identified by HPLC-MS analysis and comparison with those of the reference standards. The fi ve metabolites were characterized as danshensu (M1), caffeic acid (M2), ferulic acid (M3), isoferulic acid (M4) and methylized ferulic acid (M5), respectively. The possible metabolic pathway of the phenolic acids is proposed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15558684     DOI: 10.1002/bmc.415

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  3 in total

1.  Metabolic profile of danshen in rats by HPLC-LTQ-Orbitrap mass spectrometry.

Authors:  Huan-Huan Pang; Mei-Fang Jiang; Qin-Hui Wang; Xiao-Ye Wang; Wei Gao; Zhi-Hao Tian; Jian-Mei Huang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Mar.       Impact factor: 3.066

2.  Mechanism of tanshinones and phenolic acids from Danshen in the treatment of coronary heart disease based on co-expression network.

Authors:  Dongxue Wu; Mengqi Huo; Xi Chen; Yanling Zhang; Yanjiang Qiao
Journal:  BMC Complement Med Ther       Date:  2020-02-03

3.  A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment.

Authors:  Xiuxiu Li; Xue Xu; Jinan Wang; Hua Yu; Xia Wang; Hongjun Yang; Haiyu Xu; Shihuan Tang; Yan Li; Ling Yang; Luqi Huang; Yonghua Wang; Shengli Yang
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.